T2	Pharmacological_substance 43 57	clarithromycin
N1000 	Reference T2 MeSH:D017291	clarithromycin
T3	Pharmacological_substance 109 120	repaglinide
N1001 	Reference T3 MeSH:C072379	repaglinide
T4	Pharmacological_substance 171 191	macrolide antibiotic
T5	Pharmacological_substance 192 206	clarithromycin
N1002 	Reference T5 MeSH:D017291	clarithromycin
T6	Pharmacological_substance 255 266	repaglinide
N1003 	Reference T6 MeSH:C072379	repaglinide
T7	Pharmacological_substance 276 306	short-acting antidiabetic drug
T9	Pharmacological_substance 427 441	clarithromycin
N1004 	Reference T9 MeSH:D017291	clarithromycin
T11	Pharmacological_substance 514 528	clarithromycin
N1005 	Reference T11 MeSH:D017291	clarithromycin
T13	Pharmacological_substance 583 594	repaglinide
N1006 	Reference T13 MeSH:C072379	repaglinide
T14	Pharmacological_substance 621 632	repaglinide
N1007 	Reference T14 MeSH:C072379	repaglinide
T18	Pharmacological_substance 719 733	Clarithromycin
N1008 	Reference T18 MeSH:D017291	Clarithromycin
T19	Pharmacological_substance 802 813	repaglinide
N1009 	Reference T19 MeSH:C072379	repaglinide
T22	Pharmacological_substance 949 960	repaglinide
N1010 	Reference T22 MeSH:C072379	repaglinide
T24	Pharmacological_substance 1009 1023	clarithromycin
N1011 	Reference T24 MeSH:D017291	clarithromycin
T25	Pharmacological_substance 1034 1048	Clarithromycin
N1012 	Reference T25 MeSH:D017291	Clarithromycin
T34	Pharmacological_substance 1384 1398	clarithromycin
N1013 	Reference T34 MeSH:D017291	clarithromycin
T38	Pharmacological_substance 1475 1489	clarithromycin
N1014 	Reference T38 MeSH:D017291	clarithromycin
T39	Pharmacological_substance 1540 1551	repaglinide
N1015 	Reference T39 MeSH:C072379	repaglinide
T40	Pharmacological_substance 1574 1588	clarithromycin
N1016 	Reference T40 MeSH:D017291	clarithromycin
T43	Pharmacological_substance 1631 1642	repaglinide
N1017 	Reference T43 MeSH:C072379	repaglinide
T44	Disorder 1714 1726	hypoglycemia
N1 	Reference T44 UMLS:C0020615	hypoglycemia
T66	Subject 365 385	9 healthy volunteers
T35	Pharmacological_substance 1598 1625	potent inhibitors of CYP3A4
T42	Combination 1555 1570	Concomitant use
T57	Pharmacological_substance 445 452	placebo
N1018 	Reference T57 MeSH:D010919	placebo
T59	Pharmacological_substance 532 539	placebo
N1019 	Reference T59 MeSH:D010919	placebo
T15	Pharmacological_substance 897 904	placebo
N1020 	Reference T15 MeSH:D010919	placebo
T17	Pharmacological_substance 1261 1268	placebo
N1021 	Reference T17 MeSH:D010919	placebo
T27	Pharmacological_substance 1372 1379	placebo
N1022 	Reference T27 MeSH:D010919	placebo
T73	Speculation_cue 1706 1710	risk
